Institutional shares held 1
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap $1.16M
3,526,740 Shares Out.
Institutional ownership 0.0%
# of Institutions 1

Quarterly Institutional Activity in SPRC

Shares Bought
Shares Sold
View Transactions

Latest Institutional Activity in SPRC

Top Purchases

Q2 2023
Hrt Financial LP Shares Held: 22.4K ($7.38K)
Q2 2023
Rhumbline Advisers Shares Held: 898 ($296)
Q2 2023
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q1 2023
Virtu Financial LLC Shares Held: 42K ($13.9K)
Q1 2023
Ubs Group Ag Shares Held: 15.2K ($5K)

Top Sells

Q2 2023
Two Sigma Securities, LLC Shares Held: 21.6K ($7.14K)
Q2 2023
Susquehanna International Group, LLP Shares Held: 14.9K ($4.92K)
Q3 2022
Morgan Stanley Shares Held: 2 ($0.66)

About SPRC

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.


Insider Transactions at SPRC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on SPRC

Follow SciSparc Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRC shares.

Notify only if
Any

Insider Trading

Get notified when an Sci Sparc Ltd. insider buys or sells SPRC shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to SciSparc Ltd.

Track Activities on SPRC